3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
2
Withdrawn
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Transitional Cell Cancer of Renal Pelvis and Ureter
1
Interventions
Carboplatin
98
Cisplatin
95
pembrolizumab
90
Gemcitabine
81
Paclitaxel
80
Docetaxel
73
Capecitabine
64
Oxaliplatin
53
Specimen Handling
51
Fluorouracil
51
Magnetic Resonance Spectroscopy
49
Radiotherapy
48
Bevacizumab
48
Dexamethasone
45
Cyclophosphamide
44
Leucovorin
38
Drug Therapy
38
Irinotecan
36
Doxorubicin
36
Pemetrexed
35
Injections
30
Trastuzumab
28
Vincristine
27
Rituximab
27
Radiosurgery
25
Prednisone
25
Etoposide
25
130-nm albumin-bound paclitaxel
25
Radiation
24
Lenalidomide
24
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Recruiting
×
padeliporfin
×
Clear all
NCT04620239
2026-02-04
UCM301
Steba Biotech S.A.
Phase 3
Recruiting
100 enrolled